A European Community Advisory Board (ECAB) meeting between members from EATG and Gilead Sciences & AbbVie (September 26, 2024) and ViiV Healthcare (September 27, 2024) will be held in Brussels to discuss topics of interest to the community, such as questions related to safety and implementation of new HIV treatments.
The European Community Advisory Board (ECAB) is a platform that brings together civil society, scientific researchers, the pharmaceutical industry and other stakeholders to address key science and access issues related to HIV and its main co-infections. It is a network of individual community experts and people living with HIV who represent the diverse needs, interests, and concerns of the European HIV community. ECAB members meet regularly with key stakeholders to ensure the HIV community is represented and listened to in the research and development process.
Practical Information
- European Community Advisory Board meeting on HIV with Gilead Sciences,Abbvie & ViiV Healthcare (September 2024): Date: 26 -27 September 2024 / full day
Venue: Park Inn by Radisson Brussels Midi, Pl. Marcel Broodthaers 3, 1060 Brussels
Registration link: No registration link – only for members in the ECAB pool who applied
Related Events
-
European Community Advisory Board meeting on HIV with ViiV Healthcare, Merck Sharp and Dohme & Gilead Sciences (April 2024)
-
European Community Advisory Board meeting on HIV with Gilead Sciences, ViiV Healthcare & Janssen (September 2023)
-
European Community Advisory Board meeting with Merck Sharp and Dohme (June 2023)
-
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.